Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Jamshed Dalal"'
Autor:
Jamshed Dalal, Praveen Chandra, Rajeev Chawla, Viveka Kumar, Jabir Abdullakutty, Vidhya Natarajan, Syed Mujtaba Hussain Naqvi, Kumar Gaurav, Rahul Rathod, Gauri Dhanaki, Bhavesh Kotak, Snehal Shah
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 1, Pp 167-176 (2023)
Abstract Background Coexisting hypertension, type 2 diabetes mellitus (T2DM), and dyslipidemia (triple disease) can lead to greater risk of cardiovascular morbidity and mortality. The present study sought to comprehend the prevalence, demographic tra
Externí odkaz:
https://doaj.org/article/01b11631af384569ac197c5ca4548a3d
Autor:
Rajesh Rajput, J.C. Mohan, J.P.S. Sawhney, Jamshed Dalal, Ajit Mullasari, Hardik Vasnawala, Amit Kumar, Bharath HS, Shital Sarda
Publikováno v:
Indian Heart Journal, Vol 75, Iss 6, Pp 436-442 (2023)
Objective: Type 2 diabetes mellitus (T2DM) is known to be associated with development of left ventricular (LV) dysfunction and heart failure (HF). The study aimed to determine the prevalence of LV dysfunction and HF in unselected out-patients with T2
Externí odkaz:
https://doaj.org/article/1cf6a305c4b94e97945f32e6957f2911
Autor:
Jamshed Dalal, Anjan Lal Dutta, Jagdish Hiremath, Shamanna Seshadri Iyengar, Jagadish Chander Mohan, Abraham Ooman, Bhabadev Goswami, Kotacherry Thrivikrama Shenoy
Publikováno v:
Cardiology and Therapy, Vol 12, Iss 4, Pp 557-570 (2023)
Abstract This manuscript aims to critically evaluate the current evidence regarding adverse cardiovascular effects associated with proton pump inhibitors (PPIs) in patients with coronary artery disease (CAD). It also provides guidance for the selecti
Externí odkaz:
https://doaj.org/article/ed81eec6a5724dbd956f7b3eea38b2e0
Autor:
Jitendra PS. Sawhney, Sivasubramanian Ramakrishnan, Kushal Madan, Saumitra Ray, P Balagopalan Jayagopal, Dorairaj Prabhakaran, Tiny Nair, Geevar Zachariah, Peeyush Jain, Jamshed Dalal, Sitaraman Radhakrishnan, Arun Chopra, Sanjay Kalra, Ashwani Mehta, Arvind K. Pancholia, Nitin K. Kabra, Dhiman Kahali, Tapan Ghose, Satyavir Yadav, Prafulla Kerkar, Ajay Yadav, Debabrata Roy, Mrinal Kanti Das, Vijay H. Bang, Pratap Chandra Rath, Dhurjati Prasad Sinha, P.S. Banerjee, Rakesh Yadav, Rajeev Gupta
Publikováno v:
Indian Heart Journal, Vol 76, Iss , Pp S6-S19 (2024)
Dyslipidemias are the most important coronary artery disease (CAD) risk factor. Proper management of dyslipidemia is crucial to control the epidemic of premature CAD in India. Cardiological Society of India strived to develop consensus-based guidelin
Externí odkaz:
https://doaj.org/article/d3176ebc3e2942ed892f653a3c3a9d3c
Autor:
Jamshed Dalal, Praveen Chandra, Saumitra Ray, P. K. Hazra, Jagdish Hiremath, Viveka Kumar, Mahesh K. Shah, Jabir Abdullakutty, Debasis Ghosh, Karthik Vasudevan, Panchanan Sahoo
Publikováno v:
Cardiology and Therapy, Vol 12, Iss 3, Pp 445-471 (2023)
Abstract Heart failure is a significant public health concern characterized by notable rates of morbidity and mortality. Despite the presence of guideline-directed medical therapy (GDMT), its utilization remains inadequate. This practical recommendat
Externí odkaz:
https://doaj.org/article/b98b520f44a94a7c92b1f2e21a7b00bc
Autor:
Jagdish Chander Mohan, Jamshed Dalal, Vijay Kumar Chopra, Calambur Narasimhan, Prafulla Kerkar, Abraham Oomman, Saumitra Ray Fcsi, Anshu Rajnish Sharma, Pankaj Dougall, Shelley Simon, Atul Verma Drm, Vivek Radhakrishnan
Publikováno v:
Indian Heart Journal, Vol 74, Iss 6, Pp 441-449 (2022)
Transthyretin cardiac amyloidosis (ATTR-CM) is a rare and under-recognized disorder characterized by the aggregation of transthyretin-derived insoluble amyloid fibrils in the myocardium. Heterogeneity of symptoms at presentation, makes its diagnosis
Externí odkaz:
https://doaj.org/article/6c32440f26914cd3abf3eb45ca5a66ef
Autor:
Jamshed Dalal, J. P. Sawhney, P. B. Jayagopal, P. K. Hazra, Mohammed Yunus Khan, Kumar Gaurav, Colette Pinto, Amey Mane, Sachin Rao, Madhur Jain
Publikováno v:
International Journal of Hypertension, Vol 2022 (2022)
Introduction. Calcium channel blockers have pedal edema as one of the confining factors of treatment. A real-world study may help evident reality of the situation in regular Indian clinical practice. The aim of the study is to assess effectiveness an
Externí odkaz:
https://doaj.org/article/99c241a88ad24b38b4fc7d6f9fd60c22
Autor:
Natalie Koh, Brian A Ference, Stephen J Nicholls, Ann Marie Navar, Derek P Chew, Karam Kostner, Ben He, Hung Fat Tse, Jamshed Dalal, Anwar Santoso, Junya Ako, Hayato Tada, Jin Joo Park, Mei Lin Ong, Eric Lim, Tavin Subramaniam, Yi-Heng Li, Arintaya Phrommintikul, SS Iyengar, Saumitra Ray, Kyung Woo Park, Hong Chang Tan, Narathip Chunhamaneewat, Khung Keong Yeo, Jack Wei Chieh Tan
Publikováno v:
European Cardiology Review, Vol 16, Iss , Pp - (2021)
The prevalence of dyslipidaemia has been increasing in the Asia-Pacific region and this is attributed to dietary changes and decreasing physical activity. While there has been substantial progress in dyslipidaemia therapy, its management in the regio
Externí odkaz:
https://doaj.org/article/c1f1dcf2a27641a285019a0f13e129a2
Autor:
Jack Wei Chieh Tan, Derek P Chew, Kin Lam Tsui, Doreen Tan, Dmitry Duplyakov, Ayman Hammoudeh, Bo Zhang, Yi Li, Kai Xu, Paul J Ong, Doni Firman, Habib Gamra, Wael Almahmeed, Jamshed Dalal, Li-Wah Tam, Gabriel Steg, Quang N Nguyen, Junya Ako, Jassim Al Suwaidi, Mark Chan, Mohamed Sobhy, Abdulla Shehab, Wacin Buddhari, Zulu Wang, Alan Yean Yip Fong, Bilgehan Karadag, Byeong-Keuk Kim, Usman Baber, Chee Tang Chin, Ya Ling Han
Publikováno v:
European Cardiology Review, Vol 16, Iss , Pp - (2021)
Advanced age, diabetes, and chronic kidney disease not only increase the risk for ischaemic events in chronic coronary syndromes (CCS) but also confer a high bleeding risk during antiplatelet therapy. These special populations may warrant modificatio
Externí odkaz:
https://doaj.org/article/bffbfa97e42d4e47b8f838fe9e3ad450
Autor:
Jamshed Dalal, Aditya Kapoor
Publikováno v:
Indian Heart Journal, Vol 73, Iss 1, Pp 135-137 (2021)
Results: of the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by Percutaneous Coronary Intervention (ATPCI) study showed no significant difference in the incidence of primary endpoint events between trimeta
Externí odkaz:
https://doaj.org/article/9f7d723c05dd4fd2b88fbde97871b1e7